CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
CureVac Net Income (Quarterly) : 319.28M for Sept. 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 319.28M |
| June 30, 2025 | -67.56M |
| March 31, 2025 | -54.82M |
| December 31, 2024 | -34.95M |
| September 30, 2024 | 371.36M |
| June 30, 2024 | -78.10M |
| March 31, 2024 | -76.57M |
| December 31, 2023 | -93.19M |
| September 30, 2023 | -52.96M |
| June 30, 2023 | -73.37M |
| March 31, 2023 | -61.61M |
| December 31, 2022 | -131.37M |
| September 30, 2022 | -47.89M |
| June 30, 2022 | -61.28M |
| Date | Value |
|---|---|
| March 31, 2022 | -16.93M |
| December 31, 2021 | -2.213M |
| September 30, 2021 | -169.76M |
| June 30, 2021 | -183.32M |
| March 31, 2021 | -136.95M |
| December 31, 2020 | -69.32M |
| September 30, 2020 | -43.05M |
| June 30, 2020 | -11.33M |
| March 31, 2020 | -26.27M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -24.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alkermes Plc | 0.501M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 63.26M |
| Total Expenses (Quarterly) | -256.02M |
| EPS Diluted (Quarterly) | 1.414 |